Humacyte, Inc. (HUMA)
NASDAQ·Healthcare·Biotechnology
$0.83
+3.60%
Mkt Cap $126.34M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 27, 2026 | $1.35M | $467.00K | -65.39% | -$0.13 | -$0.13 | +0.00% | — | — |
| Q4 2025 Nov 12, 2025 | $1.35M | $753.00K | -44.18% | -$0.17 | -$0.14 | +17.65% | — | — |
| Q3 2025 Aug 11, 2025 | $917.83K | $301.00K | -67.21% | -$0.15 | -$0.24 | -60.00% | — | — |
| Q2 2025 May 13, 2025 | $764.83K | $517.00K | -32.40% | -$0.19 | -$0.10 | +47.37% | — | — |
| Q1 2025 Mar 28, 2025 | $640.20K | $7.23M | +1029.02% | -$0.23 | -$0.16 | +30.43% | — | — |
| Q4 2024 Nov 8, 2024 | $214.29K | — | — | -$0.26 | -$0.33 | -26.92% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.23 | -$0.27 | -17.39% | — | — |
| Q2 2024 May 10, 2024 | — | — | — | -$0.23 | -$0.29 | -26.09% | — | — |
| Q1 2024 Mar 22, 2024 | $60.00K | $10.79M | +17883.33% | -$0.25 | -$0.24 | +4.00% | — | — |
| Q4 2023 Nov 9, 2023 | $70.00K | — | — | -$0.25 | -$0.25 | +0.00% | — | — |
| Q3 2023 Aug 14, 2023 | $70.00K | — | — | -$0.22 | -$0.22 | +0.00% | — | — |
| Q2 2023 May 12, 2023 | $170.00K | — | — | -$0.22 | -$0.22 | +0.00% | — | — |
| Q1 2023 Mar 24, 2023 | $200.00K | $5.00K | -97.50% | -$0.24 | -$0.21 | +12.50% | — | — |
| Q4 2022 Nov 10, 2022 | $203.50K | $31.00K | -84.77% | -$0.21 | -$0.25 | -19.05% | — | — |
| Q3 2022 Aug 12, 2022 | $235.40K | $1.30M | +452.68% | -$0.22 | -$0.19 | +13.64% | — | — |
| Q2 2022 May 13, 2022 | $235.40K | $233.00K | -1.02% | -$0.21 | -$0.22 | -4.76% | — | — |
| Q1 2022 Mar 29, 2022 | $245.67K | $177.00K | -27.95% | -$0.19 | -$0.22 | -15.79% | — | — |
| Q4 2021 Nov 12, 2021 | — | $241.00K | — | -$0.21 | -$0.72 | -242.86% | — | — |
| Q3 2021 Aug 16, 2021 | — | $690.00K | — | -$0.56 | -$0.17 | +70.18% | — | — |
| Q2 2021 May 17, 2021 | — | $155.00K | — | -$0.90 | -$0.20 | +77.78% | — | — |